Article

Corneal inlay helps functional vision in presbyopic patients

San Francisco-Initial experience with a small-diameter,intracorneal lens (PresbyLens, ReVision Optics) suggests it is asafe and effective method for treating presbyopia and that itoffers the potential to expand the LASIK market, said Arturo S.Chayet, MD, at the annual meeting of the American Society ofCataract and Refractive Surgery.

The intracorneal lens is constructed of a proprietary hydrogel material that has the same index of refraction as the cornea. It is designed to be placed under a corneal flap, and the material was specifically engineered to be chemically and physically biocompatible in the cornea.

Promising technique

"This corneal inlay represents a very promising technique for enhancing functional vision in presbyopic patients undergoing hyperopic or myopic LASIK, but it can also be used to treat presbyopia in patients who are emmetropic or have had previous LASIK. Experience so far indicates the inlay procedure is simple, safe, and minimally invasive, and in contrast to excimer laser-based approaches to presbyopic treatment, this additive technology has the advantage of being removable and exchangeable. Therefore, it is able to address changes in vision that occur as presbyopia progresses," said Dr. Chayet, director, Codet Aris Laser Vision Institute, Tijuana, Mexico.

In the paired-eye study, mean preoperative MRSE was –3.29 D in eyes that underwent LASIK and received the inlay and –3.14 D in the LASIK-only eyes. For eyes that received the inlay, mean UCVA improved from 20/170 to 20/41 at distance, from 20/78 to 20/24 at intermediate, and from 20/43 to 20/28 at near. In the LASIK eyes, mean preoperative UCVA values were similar at distance, intermediate, and near. Distance UCVA was better postoperatively in the LASIK only eyes than in the eyes with the inlay (postoperative mean, 20/22), but with LASIK only there was less improvement in intermediate vision (postoperative mean, 20/41), and UCVA at near worsened to a mean of 20/75.

Safety with the inlay technology has been excellent.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.